Showing results (21-30 of 364) with videos related to
Sort By:
Pageof 37
Clinics in Geriatric Medicine|May 25, 2005
Rheumatic disease in the elderly: rheumatoid arthritisZuhre Tutuncu, Arthur KavanaughClinics in Dermatology|September 13, 2006
Rheumatoid arthritis in dermatologyTissa Hata, Arthur KavanaughRheumatic Diseases Clinics of North America|June 3, 2004
Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatmentsJeffry Bieber, Arthur KavanaughClinical and Experimental Rheumatology|October 13, 2015
Trial design in psoriatic arthritis: what could be changed?Arthur Kavanaugh, Tristan BoydExpert Opinion on Therapeutic Targets|November 22, 2007
Tumor necrosis factor as a therapeutic target of rheumatologic diseaseChristoph Ackermann, Arthur KavanaughExpert Review of Clinical Immunology|August 5, 2014
A review of disease activity measures for psoriatic arthritis: what is the best approach?Minyoung Her, Arthur KavanaughNature Reviews. Gastroenterology & Hepatology|April 22, 2015
Advances in use of immunomodulatory agents--a rheumatology perspectiveMinyoung Her, Arthur KavanaughThe Journal of Rheumatology. Supplement|July 4, 2012
Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL)Arthur Kavanaugh, Philip MeaseClinical and Experimental Rheumatology|October 20, 2012
Critical analysis of economic tools and economic measurement applied to rheumatoid arthritisMinyoung Her, Arthur KavanaughNature Reviews. Rheumatology|September 6, 2019
Bedside to bench: defining the immunopathogenesis of psoriatic arthritisArlene Bravo, Arthur KavanaughPageof 37